+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Oxidized Regenerated Cellulose Based Hemostats Market by End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5460319
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Oxidized Regenerated Cellulose Based Hemostats Market grew from USD 182.63 million in 2023 to USD 205.07 million in 2024. It is expected to continue growing at a CAGR of 12.38%, reaching USD 413.45 million by 2030.

Oxidized regenerated cellulose-based hemostats represent a crucial segment of the medical hemostatic market, designed for controlling bleeding during surgical procedures through local application. These biodegradable materials rapidly form a gel-like substance when in contact with blood, aiding in coagulation and providing an immediate response to hemorrhages. The necessity of these products primarily stems from their effectiveness, biocompatibility, and ability to reduce the need for transfusions, thereby minimizing surgical complications. With applications across diverse medical fields such as general surgery, neurosurgery, orthopedics, and cardiovascular surgery, the end-use scope is broad and critical to improving patient outcomes. Key growth factors for this market include an increasing number of surgical procedures globally, advancements in surgical techniques, and the emphasis on patient safety and reduced recovery time. The rise in healthcare expenditure and awareness about hemorrhage management further amplify demand. Emerging markets like Asia-Pacific offer considerable potential opportunities due to expanding healthcare infrastructure and increasing accessibility to advanced medical products. However, limitations include stringent regulatory standards and potential allergic reactions or inflammatory responses in patients, challenging wider adoption. Additionally, competition from alternative hemostatic agents might hinder growth. Yet, innovation remains robust, with opportunities in developing enhanced formulations that integrate additional therapeutic properties, such as antimicrobial or anti-inflammatory effects. Research focusing on improved delivery mechanisms and cost-effective production will likely unlock new business avenues. As the nature of the market leans towards rapid adoption of technologically advanced solutions, companies investing in R&D and strategic collaborations are best positioned to thrive. Overall, continuous innovation, coupled with proactive market strategies, will be pivotal in addressing the market's challenges and capitalizing on its vast opportunities.

Understanding Market Dynamics in the Oxidized Regenerated Cellulose Based Hemostats Market

The Oxidized Regenerated Cellulose Based Hemostats Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Need for advance care to manage surgical wounds
    • Rapid growth in the aging population
    • Need to ensure patient safety and render rapid recovery
    • High affordability of cellulose-based hemostats
  • Market Restraints
    • Reluctance of practitioners towards new products
    • Availability of attractive substitutes
  • Market Opportunities
    • Ongoing research and development of improved hemostats
    • Increasing demand in emerging economies
  • Market Challenges
    • Patient sensitivity issues

Exploring Porter’s Five Forces for the Oxidized Regenerated Cellulose Based Hemostats Market

Porter’s Five Forces framework further strengthens the insights of the Oxidized Regenerated Cellulose Based Hemostats Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Oxidized Regenerated Cellulose Based Hemostats Market

External macro-environmental factors deeply influence the performance of the Oxidized Regenerated Cellulose Based Hemostats Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Oxidized Regenerated Cellulose Based Hemostats Market

The Oxidized Regenerated Cellulose Based Hemostats Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Oxidized Regenerated Cellulose Based Hemostats Market

The Oxidized Regenerated Cellulose Based Hemostats Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Oxidized Regenerated Cellulose Based Hemostats Market

The Oxidized Regenerated Cellulose Based Hemostats Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oxidized Regenerated Cellulose Based Hemostats Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences, Altaylar Medical, B. Braun SE, Betatech Medical, CuraMedical B.V., GELITA MEDICAL GmbH, Hangzhou Singclean Medical Products Co., Ltd., Healthium Medtech Limited, Johnson & Johnson Services, Inc., Meril Life Sciences Pvt. Ltd., and Synthesia, a.s..

Market Segmentation & Coverage

This research report categorizes the Oxidized Regenerated Cellulose Based Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • End User
    • Clinic
    • Infectious Diseases
  • Distribution Channel
    • Direct Sales
    • Retail Sales
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for advance care to manage surgical wounds
5.1.1.2. Rapid growth in the aging population
5.1.1.3. Need to ensure patient safety and render rapid recovery
5.1.1.4. High affordability of cellulose-based hemostats
5.1.2. Restraints
5.1.2.1. Reluctance of practitioners towards new products
5.1.2.2. Availability of attractive substitutes
5.1.3. Opportunities
5.1.3.1. Ongoing research and development of improved hemostats
5.1.3.2. Increasing demand in emerging economies
5.1.4. Challenges
5.1.4.1. Patient sensitivity issues
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Oxidized Regenerated Cellulose Based Hemostats Market, by End User
6.1. Introduction
6.2. Clinic
6.3. Infectious Diseases
7. Oxidized Regenerated Cellulose Based Hemostats Market, by Distribution Channel
7.1. Introduction
7.2. Direct Sales
7.3. Retail Sales
8. Americas Oxidized Regenerated Cellulose Based Hemostats Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Oxidized Regenerated Cellulose Based Hemostats Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Oxidized Regenerated Cellulose Based Hemostats Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET RESEARCH PROCESS
FIGURE 2. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET DYNAMICS
TABLE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. CHINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. CHINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. INDIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. INDIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. JAPAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. JAPAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. THAILAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. THAILAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. DENMARK OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. EGYPT OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. EGYPT OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. FINLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. FINLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. FRANCE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. FRANCE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. GERMANY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. GERMANY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. ITALY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. ITALY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. NORWAY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. NORWAY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. POLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. POLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. QATAR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. QATAR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. SPAIN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. SPAIN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. TURKEY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. TURKEY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 100. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Oxidized Regenerated Cellulose Based Hemostats Market, which are profiled in this report, include:
  • Aegis Lifesciences
  • Altaylar Medical
  • B. Braun SE
  • Betatech Medical
  • CuraMedical B.V.
  • GELITA MEDICAL GmbH
  • Hangzhou Singclean Medical Products Co., Ltd.
  • Healthium Medtech Limited
  • Johnson & Johnson Services, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Synthesia, a.s.

Methodology

Loading
LOADING...

Table Information